I think lots of questions raised here in the past

I think lots of questions raised here in the past dozen or so posts can be answered by reading this article:

https://endpts.com/ipsen-snags-an-approved-ca...lls-cheap/

They have an APPROVED cancer drug, but the stock was knocked down 90%. Then, magically, a buyer appears with what is a horrendously low-ball price, but desperate shareholders are happy to get out with some money. $247 million buyout for an APPROVED cancer drug? A penny stock, with few shareholders and an APPROVED cancer drug?

Quote:

---

Ipsen’s buyout price came in well above the 60 odd cents Epizyme was trading for up until last week, when the price suddenly spiked before the deal was inked.
....
Epizyme shares lost 90% of their value over the past year as execs expanded the label for Tazverik while chopping staff in order to extend their runway.

---

But no, certainly there couldn't POSSIBLY be an incentive for a Big Pharma to knock down the prices of small companies so that they can buy them cheap. In another example, that must have been just an unfortunate coincidence that a certain TweeterShort claimed that he had advance knowledge that ONTY's clinical trial had failed, and then after the stock price tanked and the actual excellent clinical trial results came in, the stock didn't recover and it was bought out for less than the market cap before the results. There couldn't POSSIBLY have been any conspiracy or concerted effort for that to happen.

EDIT: And I'm quite sure it was just coincidence that the price went up BEFORE the "deal was inked."

Also, I own a bridge in Brooklyn that I will sell you cheap.